Popular Children's and Infant's Medications Recalled

Washington, DCMcNeil Consumer Healthcare, Division of McNEIL-PPC, Inc, in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children's and Infants' liquid products manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait. The recall was prompted by drug manufacturing deficiencies, according to a recent statement by the FDA.

The products under recall include certain liquid infant's and children's Tylenol®, Motrin®, Zyrtec®, and Benadryl® products. A complete list of products and lot numbers can be found here.

Some of the products included in the recall may contain a higher concentration of active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, FDA advises consumers who have purchased these recalled products to discontinue use.

April 30-10: McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants' and Children's Products [FDA: PRESS ANNOUNCEMENTS]